Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025

Same author

A Tourette Syndrome/ADHD-like Phenotype Results from Postnatal Disruption of CB<sub>1</sub> and CB<sub>2</sub> Receptor Signalling.

International journal of molecular sciences·2025

Same author

High-affinity antibodies specific to the core region of the tau protein exhibit diagnostic and therapeutic potential for Alzheimer's disease.

Alzheimer's research & therapy·2024

Same author

The Effect of Phytocannabinoids and Endocannabinoids on Nrf2 Activity in the Central Nervous System and Periphery.

Neurology international·2024

Same author

Phenothiazines: Nrf2 activation and antioxidant effects.

Journal of biochemical and molecular toxicology·2024

Same author

The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.

British journal of pharmacology·2023

Search research articles

Related Experiment Video

Updated: Aug 27, 2025

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Cyclic AMP Assay Using Human Cannabinoid CB₂ Receptor-Transfected Cells.

Pietro Marini¹, Maria Grazia Cascio¹, Roger G Pertwee²

¹School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK.

Methods in Molecular Biology (Clifton, N.J.)

|September 24, 2022

Summary

This study details a cyclic AMP assay for evaluating G-protein coupled receptor ligands. The assay utilizes nonradioligand kits and Chinese Hamster Ovarian cells expressing the human cannabinoid CB2 receptor.

Keywords:

3-Isobutyl-1-methylxanthine (IBMX)Agonist Antagonist Cannabinoid receptor type 2 Cyclic AMP Forskolin (FSK)Inverse agonist

More Related Videos

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor

Published on: March 22, 2024

Related Experiment Videos

Last Updated: Aug 27, 2025

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor

Published on: March 22, 2024

Area of Science:

Pharmacology
Biochemistry
Cell Biology

Background:

Cyclic AMP (cAMP) assays are crucial for characterizing G-protein coupled receptor (GPCR) ligand pharmacology.
Understanding ligand interactions (agonists, antagonists, inverse agonists) is vital for drug discovery.

Purpose of the Study:

To describe a practical cyclic AMP assay for assessing the pharmacological activity of ligands targeting the human cannabinoid receptor type 2 (CB2).
To demonstrate the utility of commercially available, nonradioligand assay kits.

Main Methods:

Utilized a commercially available, ready-to-use cyclic AMP assay kit.
Employed Chinese Hamster Ovarian (CHO) cells stably transfected with the human CB2 receptor.
Functional assay to measure intracellular cyclic AMP levels in response to ligand stimulation.

Main Results:

The described method enables the characterization of CB2 receptor ligand activity.
The assay is adaptable for screening agonists, antagonists, and inverse agonists.
Demonstrated successful implementation using nonradioligand kits.

Conclusions:

This cyclic AMP assay provides a robust and accessible method for evaluating cannabinoid CB2 receptor ligand pharmacology.
The use of commercial kits and stable cell lines simplifies the process for researchers.
Facilitates the study of GPCR ligand interactions in a pharmacological context.